Tokyo, May 7, 2007 (JCN Newswire) - Takara Bio Inc. (TSE: 4974) today announced that it has granted Transgenomic, Inc. a worldwide non-exclusive license to make, use and sell LA-PCR related products. Including Transgenomic, the company has nineteen (19) licensees of its LA-PCR technology worldwide. Financial terms of the license were not disclosed.
